Neurobiological mechanisms underlying relapse to cocaine use: Contributions of CRF and noradrenergic systems and regulation by glucocorticoids

Stress

Volumn 17, Issue 1, 2014, Pages 22-38

  McReynolds, Jayme R ^a   Peña, David F ^a   Blacktop, Jordan M ^a   Mantsch, John R ^a  

^a MARQUETTE UNIVERSITY   (United States)

Author keywords

Cocaine; CRF; Glucocorticoid; Norepinephrine; Relapse; Review; Stress

Indexed keywords

2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ANTALARMIN; BETA ADRENERGIC RECEPTOR; BETAXOLOL; CLENBUTEROL; CLONIDINE; COCAINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; GLUCOCORTICOID; ILLICIT DRUG; ISOPRENALINE; NORADRENALIN; PRAZOSIN; PROPRANOLOL; YOHIMBINE;

ANXIETY DISORDER; CLINICAL PRACTICE; COCAINE DEPENDENCE; CONFERENCE PAPER; DEPRESSION; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; DRUG USE; EARLY LIFE STRESS; HUMAN; IMMUNOREACTIVITY; NERVE CELL PLASTICITY; NEUROANATOMY; NEUROBIOLOGY; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RELAPSE; STRESS; STRIA TERMINALIS; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME; VENTRAL TEGMENTUM;

ADRENERGIC NEURONS; ANIMALS; BEHAVIOR, ADDICTIVE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; GLUCOCORTICOIDS; HUMANS; MODELS, ANIMAL; NEURONAL PLASTICITY; NOREPINEPHRINE; PREFRONTAL CORTEX; RECURRENCE; SELF ADMINISTRATION; SEPTAL NUCLEI; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; VENTRAL TEGMENTAL AREA;

EID: 84890909066     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2013.872617     Document Type: Conference Paper

References (187)

1. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. (1989). Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52: 1655-8.
2. Ahmed SH, Koob GF. (1997). Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology (Berl) 132: 289-95.
3. Ahmed SH, Koob GF. (1998). Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298-300.
4. Ahmed SH, Walker JR, Koob GF. (2000). Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22:413-21.
5. Anstrom KK, Miczek KA, Budygin EA. (2009). Increased phasic dopamine signaling in the mesolimbic pathway during social defeat in rats. Neuroscience 161:3-12.
6. Asanuma M, Ogawa N, Mizukawa K, Haba K, Hirata H, Mori A. (1991). Distribution of the beta-2 adrenergic receptor messenger RNA in the rat brain by in situ hybridization histochemistry: effects of chronic reserpine treatment. Neurochem Res 16:1253-6.
7. Aston-Jones G, Delfs JM, Druhan J, Zhu Y. (1999). The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci 877:486-98.
8. Back SE, Brady KT, Jaanimagi U, Jackson JL. (2006). Cocaine dependence and PTSD: a pilot study of symptom interplay and treatment preferences. Addict Behav 31:351-4.
9. Back SE, Hartwell K, DeSantis SM, Saladin M, McRae-Clark AL, Price KL, Moran-Santa Maria MM, et al. (2010). Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend 106:21-7.
10. Bale TL, Vale WW. (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-57.
11. Basso AM, Spina M, Rivier J, Vale W, Koob GF. (1999). Corticotropinreleasing factor antagonist attenuates the ''anxiogenic-like'' effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) 145: 21-30.
12. Baumann MH, Milchanowski AB, Rothman RB. (2004). Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration. Neuroscience 125:683-90.
13. Beckerman MA, Van Kempen TA, Justic NJ, Milner TA, Glass MJ. (2013). Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis. Exp Neurol 239:120-32.
14. Beckstead MJ, Gantz SC, Ford CP, Stenzel-Poore MP, Phillips PE, Mark GP, Williams JT. (2009). CRF enhancement of GIRK channelmediated transmission in dopamine neurons. Neuropsychopharmacology 34:1926-35.
15. Belej T, Manji D, Sioutis S, Barros HM, Nobrega JN. (1996). Changes in serotonin and norepinephrine uptake sites after chronic cocaine: prevs. post-withdrawal effects. Brain Res 736:287-96.
16. Berridge CW. (2008). Noradrenergic modulation of arousal. Brain Res Rev 58:1-17.
17. Beveridge TJ, Smith HR, Nader MA, Porrino LJ. (2005). Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain. Psychopharmacology (Berl) 180:781-8.
18. Blacktop JM, Seubert C, Baker DA, Ferda N, Lee G, Graf EN, Mantsch Jr. (2011). Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access selfadministration is mediated by CRF receptor type 1 but not CRF receptor type 2. J Neurosci 31:11396-403.
19. Brandon TH, Vidrine JI, Litvin EB. (2007). Relapse and relapse prevention. Annu Rev Clin Psychol 3:257-84.
20. Breese GR, Chu K, Dayas CV, Funk D, Knapp DJ, Koob GF, Le DA, et al. (2005). Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res 29:185-95.
21. Briand LA, Blendy JA. (2010). Molecular and genetic substrates linking stress and addiction. Brain Res 1314:219-34.
22. Briand LA, Vassoler FM, Pierce RC, Valentino RJ, Blendy JA. (2010). Ventral tegmental afferents in stress-induced reinstatement: the role of cAMP response element-binding protein. J Neurosci 30:16149-59.
23. Brischoux F, Chakraborty S, Brierley DI, Ungless MA. (2009). Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci U S A 106:4894-9.
24. Broadbear JH, Winger G, Cicero TJ, Woods JH. (1999). Effects of selfadministered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys. J Pharmacol Exp Ther 289:1641-7.
25. Brown SA, Vik PW, Patterson TL, Grant I, Schuckit MA. (1995). Stress, vulnerability and adult alcohol relapse. J Stud Alcohol 56:538-45.
26. Brown ZJ, Tribe E, D'Souza NA, Erb S. (2009). Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 203:121-30.
27. Brown ZJ, Nobrega JN, Erb S. (2011). Central injections of noradrenaline induce reinstatement of cocaine seeking and increase c-fos mRNA expression in the extended amygdala. Behav Brain Res 217: 472-6.
28. Bruijnzeel AW, Prado M, Isaac S. (2009). Corticotropin-releasing factor- 1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiatry 66: 110-7.
29. Budygin EA, Park J, Bass CE, Grinevich VP, Bonin KD, Wightman RM. (2012). Aversive stimulus differentially triggers subsecond dopamine release in reward regions. Neuroscience 201:331-7.
30. Buffalari DM, Baldwin CK, Feltenstein MW, See RE. (2012). Corticotrophin releasing factor (CRF) induced reinstatement of cocaine seeking in male and female rats. Physiol Behav 105: 209-14.
31. Buffalari DM, See RE. (2009). Footshock stress potentiates cue-induced cocaine-seeking in an animal model of relapse. Physiol Behav 98: 614-7.
32. Capriles N, Rodaros D, Sorge RE, Stewart J. (2003). A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 168:66-74.
33. Charlton BG, Ferrier IN, Perry RH. (1987). Distribution of corticotropinreleasing factor-like immunoreactivity in human brain. Neuropeptides 10:329-34.
34. Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, Ferguson D, et al. (2013). Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493: 532-6.
35. Chen KW, Banducci AN, Guller L, Macatee RJ, Lavelle A, Daughters SB, Lejuez CW. (2011). An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program. Drug Alcohol Depend 118:92-9.
36. Coffey SF, Saladin ME, Drobes DJ, Brady KT, Dansky BS, Kilpatrick DG. (2002). Trauma and substance cue reactivity in individuals with comorbid posttraumatic stress disorder and cocaine or alcohol dependence. Drug Alcohol Depend 65:115-27.
37. Constantinou N, Morgan CJ, Battistella S, O'Ryan D, Davis P, Curran HV. (2010). Attentional bias, inhibitory control and acute stress in current and former opiate addicts. Drug Alcohol Depend 109: 220-5.
38. Dautzenberg FM, Hauger RL. (2002). The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23: 71-7.
39. de Jong IE, Steenbergen PJ, de Kloet ER. (2009). Behavioral sensitization to cocaine: cooperation between glucocorticoids and epinephrine. Psychopharmacology 204:693-703.
40. De La Garza 2nd R, Ashbrook LH, Evans SE, Jacobsen CA, Kalechstein AD, Newton TF. (2009). Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers. Am J Addict 18:481-7.
41. Deroche V, Marinelli M, Maccari S, Le Moal M, Simon H, Piazza PV. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J Neurosci 15:7181-8.
42. Deutch AY, Lee MC, Gillham MH, Cameron DA, Goldstein M, Iadarola MJ. (1991). Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex 1: 273-92.
43. Di Chiara G, Loddo P, Tanda G. (1999). Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression. Biol Psychiatry 46:1624-33.
44. Dumont EC, Williams JT. (2004). Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 24:8198-204.
45. Duncan E, Boshoven W, Harenski K, Fiallos A, Tracy H, Jovanovic T, Hu X, et al. (2007). An fMRI study of the interaction of stress and cocaine cues on cocaine craving in cocaine-dependent men. Am J Addict 16:174-82.
46. Dunn AJ, Berridge CW. (1990). Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 15:71-100.
47. Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, Blakely RD, Winder DG. (2005). Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology 30:657-68.
48. Egli RE, Winder DG. (2003). Dorsal and ventral distribution of excitable and synaptic properties of neurons of the bed nucleus of the stria terminalis. J Neurophysiol 90:405-14.
49. Enoch MA. (2011). The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmacology (Berl) 214:17-31.
50. Erb S, Funk D, Le AD. (2005). Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine preexposure on CRF-induced locomotor activity. Neurosci Lett 383: 209-14.
51. Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J. (2000). Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23: 138-50.
52. Erb S, Petrovic A, Yi D, Kayyali H. (2006). Central injections of CRF reinstate cocaine seeking in rats after postinjection delays of up to 3 h: an influence of time and environmental context. Psychopharmacology (Berl) 187:112-20.
53. Erb S, Salmaso N, Rodaros D, Stewart J. (2001). A role for the CRFcontaining pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 158:360-5.
54. Erb S, Shaham Y, Stewart J. (1996). Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berl) 128:408-12.
55. Erb S, Shaham Y, Stewart J. (1998). The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18:5529-36.
56. Erb S, Stewart J. (1999). A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin- releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19:RC35.
57. Fan Y, Chen P, Li Y, Cui K, Noel DM, Cummins ED, Peterson DJ, et al. (2013). Corticosterone administration up-regulated expression of norepinephrine transporter and dopamine b-hydroxylase in rat locus coeruleus and its terminal regions. J Neurochem. [Epub ahead of print]. doi: 10.1111/jnc.12459.
58. Feltenstein MW, See RE. (2006). Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav Brain Res 174:1-8.
59. Fox HC, Hong KI, Siedlarz K, Sinha R. (2008). Enhanced sensitivity to stress and drug/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers. Neuropsychopharmacology 33:796-805.
60. Fox HC, Talih M, Malison R, Anderson GM, Kreek MJ, Sinha R. (2005). Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues. Psychoneuroendocrinology 30:880-91.
61. Fuchs RA, Evans KA, Ledford CC, Parker MP, Case JM, Mehta RH, See RE. (2005). The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 30:296-309.
62. Georges F, Aston-Jones G. (2001). Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. J Neurosci 21:RC160.
63. Georges F, Aston-Jones G. (2002). Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22: 5173-87.
64. Goeders NE, Bienvenu OJ, De Souza EB. (1990). Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res 531:322-8.
65. Graf EN, Hoks MA, Baumgardner J, Sierra J, Vranjkovic O, Bohr C, Baker DA, Mantsch Jr. (2011). Adrenal activity during repeated longaccess cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats. Neuropsychopharmacology 36:1444-54.
66. Graf EN, Wheeler RA, Baker DA, Ebben AL, Hill JE, McReynolds JR, Robble MA, et al. (2013). Corticosterone acts in the nucleus accumbens to enhance dopamine signaling and potentiate reinstatement of cocaine seeking. J Neurosci 33:11800-10.
67. Grammatopoulos DK. (2012). Insights into mechanisms of corticotropinreleasing hormone receptor signal transduction. Br J Pharmacol 166: 85-97.
68. Graziane NM, Polter AM, Briand LA, Pierce RC, Kauer JA. (2013). Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. Neuron 77:942-54.
69. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. (1995). Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65:111-16.
70. Hahn J, Hopf FW, Bonci A. (2009). Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J Neurosci 29:6535-44.
71. Horger BA, Roth RH. (1996). The role of mesoprefrontal dopamine neurons in stress. Crit Rev Neurobiol 10:395-418.
72. Hyman SM, Paliwal P, Chaplin TM, Mazure CM, Rounsaville BJ, Sinha R. (2008). Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Depend 92: 208-16.
73. Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, Kash TL, Stuber GD. (2013). Distinct extended amygdala circuits for divergent motivational states. Nature 496:224-8.
74. Jhanwar-Uniyal M, Leibowitz SF. (1986). Impact of circulating corticosterone on alpha 1- and alpha 2-noradrenergic receptors in discrete brain areas. Brain Res 368:404-8.
75. Jobes ML, Ghitza UE, Epstein DH, Phillips KA, Heishman SJ, Preston KL. (2011). Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl) 218:83-8.
76. Joe?ls M, Bouma G, Hesen W, Zegers Y. (1991). Increased effect of noradrenaline on synaptic responses in rat CA1 hippocampal area after adrenalectomy. Brain Res 550:347-52.
77. Kalivas PW, Duffy P. (1995). Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 675:325-8.
78. Kalivas PW, McFarland K. (2003). Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168:44-56.
79. Kash TL, Nobis WP, Matthews RT, Winder DG. (2008). Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J Neurosci 28: 13856-65.
80. Khoury L, Tang YL, Bradley B, Cubells JF, Ressler KJ. (2010). Substance use, childhood traumatic experience, and posttraumatic stress disorder in an urban civilian population. Depress Anxiety 27: 1077-86.
81. Kippin TE, Fuchs RA, See RE. (2006). Contributions of prolonged contingent and noncontingent cocaine exposure to enhanced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 187: 60-7.
82. Koob G, Kreek MJ. (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149-59.
83. Koob GF. (2008). A role for brain stress systems in addiction. Neuron 59:11-34.
84. Koob GF. (2010). The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 1314:3-14.
85. Koob GF, Volkow ND. (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35:217-38.
86. Korotkova TM, Brown RE, Sergeeva OA, Ponomarenko AA, Haas HL. (2006). Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci 23:2677-85.
87. Kreibich AS, Blendy JA. (2004). cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement. J Neurosci 24:6686-92.
88. Kudo T, Uchigashima M, Miyazaki T, Konno K, Yamasaki M, Yanagawa Y, Minami M, Watanabe M. (2012). Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. J Neurosci 32:18035-46.
89. Lammel S, Ion DI, Roeper J, Malenka RC. (2011). Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70:855-62.
90. Lammel S, Lim BK, Ran C, Huang KW, Betley MJ, Tye KM, Deisseroth K, Malenka RC. (2012). Input-specific control of reward and aversion in the ventral tegmental area. Nature 491:212-17.
91. Lanteri C, Salomon L, Torrens Y, Glowinski J, Tassin JP. (2008). Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Neuropsychopharmacology 33: 1724-34.
92. Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y. (2005). Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl) 179:366-73.
93. Lê AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y. (2000). The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 150: 317-24.
94. Lê AD, Funk D, Juzytsch W, Coen K, Navarre BM, Cifani C, Shaham Y. (2011). Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats. Psychopharmacology (Berl) 218:89-99.
95. Leeies M, Pagura J, Sareen J, Bolton JM. (2010). The use of alcohol and drugs to self-medicate symptoms of posttraumatic stress disorder. Depress Anxiety 27:731-6.
96. Lemos JC, Wanat MJ, Smith JS, Reyes BA, Hollon NG, Van Bockstaele EJ, Chavkin C, Phillips PE. (2012). Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature 490: 402-6.
97. Leri F, Flores J, Rodaros D, Stewart J. (2002). Blockade of stressinduced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22: 5713-18.
98. Lodge DJ, Grace AA. (2005). Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity. J Pharmacol Exp Ther 314: 201-6.
99. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T. (1995). Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-40.
100. Macey DJ, Smith HR, Nader MA, Porrino LJ. (2003). Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey. J Neurosci 23:12-6.
101. Mameli M, Bellone C, Brown MT, Luscher C. (2011). Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area. Nat Neurosci 14:414-6.
102. Mantsch JR, Baker DA, Francis DM, Katz ES, Hoks MA, Serge JP. (2008). Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. Psychopharmacology (Berl) 195:591-603.
103. Mantsch JR, Cullinan WE, Tang LC, Baker DA, Katz ES, Hoks MA, Ziegler DR. (2007). Daily cocaine self-administration under longaccess conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats. Brain Res 1167:101-11.
104. Mantsch JR, Katz ES. (2007). Elevation of glucocorticoids is necessary but not sufficient for the escalation of cocaine self-administration by chronic electric footshock stress in rats. Neuropsychopharmacology 32:367-76.
105. Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, Caretta H. (2010). Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for beta- 2 adrenergic receptors. Neuropsychopharmacology 35:2165-78.
106. Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ. (2003). Neuroendocrine alterations in a high-dose, extended-access rat selfadministration model of escalating cocaine use. Psychoneuroendocrinology 28:836-62.
107. Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ. (2004). Effects of extended access to high versus low cocaine doses on selfadministration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology (Berl) 175:26-36.
108. McCutcheon JE, Ebner SR, Loriaux AL, Roitman MF. (2012). Encoding of aversion by dopamine and the nucleus accumbens. Front Neurosci 6:137.
109. McFarland K, Davidge SB, Lapish CC, Kalivas PW. (2004). Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci 24:1551-60.
110. McLaughlin JP, Marton-Popovici M, Chavkin C. (2003). Kappa opioid receptor antagonism and prodynorphin gene disruption block stressinduced behavioral responses. J Neurosci 23:5674-83.
111. McRae-Clark AL, Carter RE, Price KL, Baker NL, Thomas S, Saladin ME, Giarla K, et al. (2011). Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals. Psychopharmacology (Berl) 218:49-58.
112. Meil WM, See RE. (1997). Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res 87: 139-48.
113. Mitrano DA, Pare JF, Smith Y, Weinshenker D. (2014). D1-dopamine and a1-adrenergic receptors co-localize in dendrites of the rat prefrontal cortex. Neuroscience 258:90-100.
114. Mitrano DA, Schroeder JP, Smith Y, Cortright JJ, Bubula N, Vezina P, Weinshenker D. (2012). a-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology 37: 2161-72.
115. Mobley PL, Manier DH, Sulser F. (1983). Norepinephrine-sensitive adenylate cyclase system in rat brain: role of adrenal corticosteroids. J Pharmacol Exp Ther 226:71-7.
116. Nobis WP, Kash TL, Silberman Y, Winder DG. (2011). Beta-adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophin-releasing factor receptordependent and cocaine-regulated mechanism. Biol Psychiatry 69: 1083-90.
117. Oleson EB, Gentry RN, Chioma VC, Cheer JF. (2012). Subsecond dopamine release in the nucleus accumbens predicts conditioned punishment and its successful avoidance. J Neurosci 32: 14804-8.
118. Orozco-Cabal L, Pollandt S, Liu J, Shinnick-Gallagher P, Gallagher JP. (2006). Regulation of synaptic transmission by CRF receptors. Rev Neurosci 17:279-307.
119. Park J, Wheeler RA, Fontillas K, Keithley RB, Carelli RM, Wightman RM. (2012). Catecholamines in the bed nucleus of the stria terminalis reciprocally respond to reward and aversion. Biol Psychiatry 71:327-34.
120. Pollandt S, Liu J, Orozco-Cabal L, Grigoriadis DE, Vale WW, Gallagher JP, Shinnick-Gallagher P. (2006). Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur J Neurosci 24:1733-43.
121. Preston KL, Epstein DH. (2011). Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl) 218:29-37.
122. Rainbow TC, Parsons B, Wolfe BB. (1984). Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain. Proc Natl Acad Sci U S A 81:1585-9.
123. Ratka A, Sutanto W, Bloemers M, de Kloet ER. (1989). On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50:117-23.
124. Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, Dedic N, et al. (2011). Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 333: 1903-7.
125. Richter RM, Weiss F. (1999). In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32:254-61.
126. Rivier C, Vale W. (1987). Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)- mediated mechanism. Brain Res 422:403-6.
127. Robinson TE, Berridge KC. (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-91.
128. Rodaros D, Caruana DA, Amir S, Stewart J. (2007). Corticotropinreleasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience 150:8-13.
129. Roitman MF, Wheeler RA, Wightman RM, Carelli RM. (2008). Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli. Nat Neurosci 11:1376-7.
130. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. (1991). Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48:43-51.
131. Saal D, Dong Y, Bonci A, Malenka RC. (2003). Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-82.
132. Saladin ME, Drobes DJ, Coffey SF, Dansky BS, Brady KT, Kilpatrick DG. (2003). PTSD symptom severity as a predictor of cue-elicited drug craving in victims of violent crime. Addict Behav 28:1611-29.
133. Sanchez CJ, Bailie TM, Wu WR, Li N, Sorg BA. (2003). Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior. Neuroscience 119:497-505.
134. Sartor GC, Aston-Jones G. (2012). Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference. Eur J Neurosci 36:3549-58.
135. Schank JR, King CE, Sun H, Cheng K, Rice KC, Heilig M, Weinshenker D, Schroeder JP. (2013). The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking. Neuropsychopharmacology. [Epub ahead of print]. doi: 10.1038/npp.2013.309.
136. Schulkin J, Gold PW, McEwen BS. (1998). Induction of corticotropinreleasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 23:219-43.
137. Schultz W. (2007). Multiple dopamine functions at different time courses. Annu Rev Neurosci 30:259-88.
138. Seamans JK, Gorelova N, Durstewitz D, Yang CR. (2001). Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21:3628-38.
139. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J. (1998). CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) 137: 184-90.
140. Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J. (1997). Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17: 2605-14.
141. Shaham Y, Highfield D, Delfs J, Leung S, Stewart J. (2000). Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 12:292-302.
142. Shin JW, Geerling JC, Loewy AD. (2008). Inputs to the ventrolateral bed nucleus of the stria terminalis. J Comp Neurol 511:628-57.
143. Silberman Y, Matthews RT, Winder DG. (2013). A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis. J Neurosci 33:950-60.
144. Silberman Y, Winder DG. (2013). Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward. Front Psychiatry 4:42.
145. Sinha R. (2009). Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol 14: 84-98.
146. Sinha R, Catapano D, O'Malley S. (1999). Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology (Berl) 142:343-51.
147. Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ. (2006). Stressinduced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63: 324-31.
148. Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM. (2009). Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34:1198-208.
149. Sinha R, Shaham Y, Heilig M. (2011). Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology (Berl) 218:69-82.
150. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ. (2003). Hypothalamic-pituitary-adrenal axis and sympatho-adrenomedullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 170:62-72.
151. Specio SE, Wee S, O'Dell LE, Boutrel B, Zorrilla EP, Koob GF. (2008). CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berl) 196:473-82.
152. Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, Krystal JH. (2002). Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry 51: 642-51.
153. Substance Abuse and Mental Health Services Administration (SAMHSA). (2012). Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-45, HHS Publication No. (SMA) 12-4725. Rockville, MD: Substance Abuse and Mental Health Services Administration.
154. Swanson LW, Sawchenko PE, Rivier J, Vale WW. (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-86.
155. Tagliaferro P, Morales M. (2008). Synapses between corticotropinreleasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J Comp Neurol 506:616-26.
156. Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S. (2009). Teneurin C-terminal associated peptide (TCAP)-1 attenuates corticotropinreleasing factor (CRF)-induced c-Fos expression in the limbic system and modulates anxiety behavior in male Wistar rats. Behav Brain Res 201:198-206.
157. Tassin JP, Studler JM, Hervé D, Blanc G, Glowinski J. (1986). Contribution of noradrenergic neurons to the regulation of dopaminergic (D1) receptor denervation supersensitivity in rat prefrontal cortex. J Neurochem 46:243-8.
158. Tidey JW, Miczek KA. (1996). Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res 721:140-9.
159. Ungless MA, Argilli E, Bonci A. (2010). Effects of stress and aversion on dopamine neurons: implications for addiction. Neurosci Biobehav Rev 35:151-6.
160. Ungless MA, Magill PJ, Bolam JP. (2004). Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303:2040-2.
161. Ungless MA, Singh V, Crowder TL, Yaka R, Ron D, Bonci A. (2003). Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 39:401-7.
162. Ungless MA, Whistler JL, Malenka RC, Bonci A. (2001). Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411:583-7.
163. Vale W, Spiess J, Rivier C, Rivier J. (1981). Characterization of a 41- residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-7.
164. Valenti O, Lodge DJ, Grace AA. (2011). Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus. J Neurosci 31:4280-9.
165. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, et al. (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212.
166. Vendruscolo LF, Barbier E, Schlosburg JE, Misra KK, Whitfield Jr. TW, Logrip ML, Rivier C, et al. (2012). Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci 32: 7563-71.
167. Vranjkovic O, Hang S, Baker DA, Mantsch Jr. (2012). beta-adrenergic receptor mediation of stress-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: roles for beta1 and beta2 adrenergic receptors. J Pharmacol Exp Ther 342:541-51.
168. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A. (2008). Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol 586:2157-70.
169. Wanat MJ, Bonci A, Phillips PE. (2013). CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors. Nat Neurosci 16:383-5.
170. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB. (2005). Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 25:5389-96.
171. Wang B, You ZB, Rice KC, Wise RA. (2007). Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl) 193:283-94.
172. Wang B, You ZB, Wise RA. (2012). Heroin self-administration experience establishes control of ventral tegmental glutamate release by stress and environmental stimuli. Neuropsychopharmacology 37: 2863-9.
173. Wang HL, Morales M. (2008). Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. J Comp Neurol 509:302-18.
174. Wang X, Cen X, Lu L. (2001). Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol 432: 153-61.
175. Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW. (1999). Blockade of cocaine-induced increases in adrenocorticotrophic hormone and cortisol does not attenuate the subjective effects of smoked cocaine in humans. Behav Pharmacol 10:523-9.
176. Wee S, Mandyam CD, Lekic DM, Koob GF. (2008). Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access. Eur Neuropsychopharmacol 18: 303-11.
177. Weinshenker D, Schroeder JP. (2007). There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32: 1433-51.
178. Wichmann R, Fornari RV, Roozendaal B. (2012). Glucocorticoids interact with the noradrenergic arousal system in the nucleus accumbens shell to enhance memory consolidation of both appetitive and aversive taste learning. Neurobiol Learn Mem 98:197-205.
179. Wise RA, Rompre PP. (1989). Brain dopamine and reward. Annu Rev Psychol 40:191-225.
180. Wise RA, Morales M. (2010). A ventral tegmental CRF-glutamatedopamine interaction in addiction. Brain Res 1314:38-43.
181. Xu TX, Yao WD. (2010). D1 and D2 dopamine receptors in separate circuits cooperate to drive associative long-term potentiation in the prefrontal cortex. Proc Natl Acad Sci U S A 107:16366-71.
182. Yamada H, Bruijnzeel AW. (2011). Stimulation of a2-adrenergic receptors in the central nucleus of the amygdala attenuates stressinduced reinstatement of nicotine seeking in rats. Neuropharmacology 60:303-11.
183. Zahm DS, Jensen SL, Williams ES, Martin 3rd JR, (1999). Direct comparison of projections from the central amygdaloid region and nucleus accumbens shell. Eur J Neurosci 11:1119-26.
184. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ. (1996). Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during ''binge''-pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther 279:351-8.
185. Zhou Y, Spangler R, Schlussman SD, Ho A, Kreek MJ. (2003). Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormonereceptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal. Brain Res 964:187-99.
186. Zorrilla EP, Valdez GR, Weiss F. (2001). Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 158:374-81.
187. Zorrilla EP, Wee S, Zhao Y, Specio S, Boutrel B, Koob GF, Weiss F. (2012). Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats. Addict Biol 17:300-8.